# EDGAR Filing Document

**Accession Number:** 0001333565
**File Stem:** 0000097216-23-000076
**Filing Date:** 2023-3
**Character Count:** 7624
**Document Hash:** 58fad1581cccbb3cf76aa60666100b6e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000097216-23-000076.hdr.sgml**: 20230316

**ACCESSION NUMBER**: 0000097216-23-000076

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230315

**FILED AS OF DATE**: 20230316

**DATE AS OF CHANGE**: 20230316

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** BECK JULIE A
- **CENTRAL INDEX KEY:** 0001333565

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-10702
- **FILM NUMBER:** 23740172

**MAIL ADDRESS:**
- **STREET 1:** ONE INVACARE WAY
- **CITY:** ELYRIA
- **STATE:** OH
- **ZIP:** 44035
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TEREX CORP
- **CENTRAL INDEX KEY:** 0000097216
- **STANDARD INDUSTRIAL CLASSIFICATION:** INDUSTRIAL TRUCKS TRACTORS TRAILERS & STACKERS [3537]
- **IRS NUMBER:** 341531521
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 45 GLOVER AVENUE
- **STREET 2:** 4TH FLOOR
- **CITY:** NORWALK
- **STATE:** CT
- **ZIP:** 06850
- **BUSINESS PHONE:** 2032227170

**MAIL ADDRESS:**
- **STREET 1:** 45 GLOVER AVENUE
- **STREET 2:** 4TH FLOOR
- **CITY:** NORWALK
- **STATE:** CT
- **ZIP:** 06850

## Ex-24

```
<pre>

POWER OF ATTORNEY

    KNOW ALL MEN BY THESE PRESENTS THAT I, JULIE BECK, hereby
make, constitute and appoint SCOTT J. POSNER and MELISSA KLAUDER, as my true
and lawful attorneys-in-fact, to execute and file all instruments, documents, certificates
and other items required to be executed and filed with the Securities and Exchange
Commission by me under and pursuant to Section 16(a) of the Securities and Exchange
Act of 1934, as amended, as a result of my position with TEREX CORPORATION,
including, without limitation, all Forms 3, 4 and 5 that may be required as a result of my
transactions in equity securities of TEREX CORPORATION while a director or officer
of TEREX CORPORATION.

    IN WITNESS WHEREOF, I have hereunto set my hand this 1st day of
November, 2021.

                        /s/Julie Beck___________
                        Julie Beck

</pre>
```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>BECK JULIE A<br><sub>(Last) (First) (Middle)</sub><br>C/O TEREX CORPORATION<br>45 GLOVER AVENUE<br><sub>(Street)</sub><br>NORWALK, CT 06850<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-03-15 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Senior Vice President, CFO_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>TEREX CORP [ TEX ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock, $.01 par value | 2023-03-15 |  | A |  | 8282<sup>(1)</sup> | A | $0 | 44381 | D |  |
| Common Stock, $.01 par value | 2023-03-15 |  | A |  | 8282<sup>(2)</sup> | A | $0 | 52663 | D |  |
| Common Stock, $.01 par value | 2023-03-15 |  | A |  | 8919<sup>(3)</sup> | A | $0 | 61582 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) Shares granted pursuant to one of the Company's long-term incentive plans with the award scheduled to vest in the first quarter of 2026 if the Company achieves a targeted percentile rank against a peer group of companies for three year annualized total shareholder return ("TSR") for the period January 1, 2023 - December 31, 2025. The number of shares in this grant are subject to adjustment, up or down, based upon attainment above or below the targeted percentile rank.

(2) Shares granted pursuant to one of the Company's long-term incentive plans with the award scheduled to vest in the first quarter of 2026 if the Company achieves a targeted return on invested capital ("ROIC") in each of 2023, 2024 and 2025. The number of shares in this grant are subject to adjustment, up or down, based upon attainment above or below the targeted ROIC.

(3) Shares granted pursuant to one of the Company's long-term incentive plans with the award vesting as follows: 1/3 on March 15, 2024; 1/3 on March 15, 2025 and 1/3 on March 15, 2026.

**Signature:** /s/Scott J. Posner, by power of attorney  
**Date:** 2023-03-16

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**